1. Home
  2. UAL vs NTRA Comparison

UAL vs NTRA Comparison

Compare UAL & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Airlines Holdings Inc.

UAL

United Airlines Holdings Inc.

HOLD

Current Price

$92.70

Market Cap

30.0B

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$195.66

Market Cap

28.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UAL
NTRA
Founded
1934
2003
Country
United States
United States
Employees
87000
6140
Industry
Air Freight/Delivery Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.0B
28.2B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
UAL
NTRA
Price
$92.70
$195.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
15
Target Price
$130.12
$259.07
AVG Volume (30 Days)
5.6M
1.4M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
7.94
0.65
EPS
2.14
N/A
Revenue
$37,736,000,000.00
$210,939,000.00
Revenue This Year
$11.70
$18.08
Revenue Next Year
$5.06
$19.65
P/E Ratio
$43.60
N/A
Revenue Growth
3.23
N/A
52 Week Low
$71.55
$131.81
52 Week High
$119.21
$256.36

Technical Indicators

Market Signals
Indicator
UAL
NTRA
Relative Strength Index (RSI) 46.00 45.98
Support Level $89.02 $187.27
Resistance Level $101.39 $220.74
Average True Range (ATR) 3.07 11.08
MACD -0.05 -1.72
Stochastic Oscillator 30.25 27.70

Price Performance

Historical Comparison
UAL
NTRA

About UAL United Airlines Holdings Inc.

Chicago-based United Airlines is a major US network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel, especially across the Pacific, than its large US peers.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: